ABcann Global Corporation (TSX.V: Abcn) (OTCQB: Abccf) Announces Close of $15 Million Investment from Cannabis Wheaton

ABcann Global Corporation (TSX.V: Abcn) (OTCQB: Abccf) Announces Close of $15 Million Investment from Cannabis Wheaton
ABcann Global Corporation (TSX.V: Abcn) (OTCQB: Abccf) Announces Close of $15 Million Investment from Cannabis Wheaton

ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the completion of Cannabis Wheaton Income Corp.’s (TSX.V: CBW) previously detailed purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share. “We are pleased to have completed the initial funding phase of our partnership with Cannabis Wheaton and to welcome them as new equity holders in ABcann,” Aaron Keay, chief executive officer of ABcann, stated in the news release. “The initial investment represents Cannabis Wheaton’s first funding allocation and we look forward to future investment from them, as both companies advance our respective businesses.” Per the update, this initial investment forms part of a larger phased investment by Cannabis Wheaton that’s expected to fund an additional 50,000 square feet at ABcann’s second production facility. This expansion comes alongside ABcann’s existing construction plans for a 100,000 square foot purpose built facility at its Kimmett property in Napanee, Ontario.

To view the full press release, visit http://nnw.fm/aVAL7

About ABcann Global Corporation

ABcann was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. For more information, visit www.ABcannGlobal.com

Read original release here


Read More